Why the Bull Case for Intuitive Surgical Stock Is Long Term Medical Robotics Dominance

Intuitive Surgical controls 80% of robotic surgery, making surgeon lock-in its most durable competitive advantage.

Intuitive Surgical controls 80% of robotic surgery, making surgeon lock-in its most durable competitive advantage.

Nvidia's future growth depends partly on whether robotics AI deployment scales faster than skeptics expect.

Nauticus's subsea robot partnerships prove the technology works, but mounting losses and cash depletion put execution on a razor's edge.

PROCEPT BioRobotics bypassed the crowded general-purpose surgical robot market to dominate a specific, high-volume procedure where focused engineering beats platform sprawl.

Hundreds of paying robotics customers, rising margins, and a bargain multiple — the case for Ouster as the lidar sector's overlooked value play.

The company's robots—small, wheeled vehicles designed to navigate pedestrian pathways—are expanding into major cities because they solve a specific...

Knightscope's 106% quarterly revenue growth and $40 billion addressable market mask a company burning $21.9 million in EBITDA annually with only $11.4 million in cash.

AgEagle's sub-$5 share price reflects structural disadvantages of penny stock status and modest profitability, not hidden value in drone services.

Microbot Medical trades under $1 because clinical approval remains unproven and revenue is minimal while cash burn continues relentlessly.

Richtech Robotics' stock surge reflects real partnerships and product demonstrations, not speculation—though valuation multiples suggest flawless execution ahead.